In the Fall 2016 American Academy of Pediatrics (AAP) Newsletter, incoming Chair of the Section on Advances in Therapeutics and Technology (SOATT) Dr. Mitchell Reid Goldsten focuses on the need to improve medical innovation for neonates. "There is no excuse for lack of acceptable pediatric devices or medications due to inadequate resources for research and development," he writes. "The Promoting Life Saving New Therapies for Neonates Act of 2015 (S. 2041 and H.R. 5182) is an example of legislation designed to bridge the gap... This legislation would mark a promising step forward in creating appropriate incentives to bring new treatments forward to benefit this vulnerable population."
| soatt newsletter article.pdf |
